EAM talks to Gambian counterpart on kids' death linked to cough syrups

Dr S. Jaishankar spoke to his Gambian counterpart Dr. Mamadou Tangara and conveyed condolences on the deaths of young children allegedly linked to the contaminated cough syrups produced in India

S Jaishankar
External Affairs Minister S Jaishankar
IANS New Delhi
2 min read Last Updated : Oct 13 2022 | 7:20 PM IST

External Affairs Minister Dr S. Jaishankar on Thursday spoke to his Gambian counterpart Dr. Mamadou Tangara and conveyed condolences on the deaths of young children allegedly linked to the contaminated cough syrups produced in India.

He assured Tangara that serious investigation is being undertaken by appropriate authorities in India to ascertain the facts over World Health Organisation alerts of India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 children's death".

"In a telecon with Gambian FM Dr. Mamadou Tangara, conveyed our deepest condolences on the deaths of young children recently. Underlined that matter is being seriously investigated by appropriate authorities. We agreed to remain in touch," the Minister said in a tweet.

The World Health Organisation had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".

Meanwhile, the centre has formed a four-member panel to analysis and examine the detailed report shared by the World Health Organisation on the issue.

The committee will examining and analysing adverse event reports, causal relationship and all related details shared by WHO, and will suitably advise and recommend to the DCGI about further course of action. The committee will be chaired by Dr Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines.

--IANS

avr/vd

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :S JaishankarGambiaCough syrup

First Published: Oct 13 2022 | 7:20 PM IST

Next Story